Live from the NIH registry
Studies recruiting near Torrance right now
Top 25 of 3,258 recruiting studies, sorted by proximity — each links to its official registry page
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (16.1 mi)
· Sponsor: University of Pennsylvania
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) — Orange, California (28.2 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Group of Southern California — Los Angeles, California (16.1 mi)
· Sponsor: Pacific Edge Limited
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
The Regents of the University of California, Los Angeles — Los Angeles, California (16.1 mi)
· Sponsor: University of Pittsburgh
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
UCLA Care — Los Angeles, California (16.1 mi)
· Sponsor: Westat
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0135) — Burbank, California (24.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (16.1 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retina-Vitreous Associates Medical Group — Beverly Hills, California (16.9 mi)
· Sponsor: Boehringer Ingelheim
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Low-Risk, Early Stage Breast Cancer
N/A
Interventional 400 participants sought
Glendale Adventist Medical Center d/b/a Adventist Health Glendale — Glendale, California (21.8 mi)
· Sponsor: IceCure Medical Ltd.
Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)
Actinic Keratosis (AK)
N/A
Observational 30 participants sought
Ablon Skin Institute and Research Center — Manhattan Beach, California (5.3 mi)
· Sponsor: Avant Health LLC
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
Children's Hospital Orange County — Orange, California (28.2 mi)
· Sponsor: New York Medical College
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Necrotizing Soft Tissue Infection
N/A
Observational 50 participants sought
University of California Irvine Medical Center — Orange, California (28.2 mi)
· Sponsor: University of California, Irvine
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Miller Children's and Women's Hospital Long Beach — Long Beach, California (9.9 mi)
· Sponsor: National Cancer Institute (NCI)
Motivation for IV Alcohol Self-Administration in Humans
Alcohol Use Disorder
Phase 2
Interventional 210 participants sought
University of California, Los Angeles — Los Angeles, California (16.1 mi)
· Sponsor: University of California, Los Angeles
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
Spinal Cord Injury, Pressure Injury
N/A
Interventional 808 participants sought
VA Long Beach Healthcare System, Long Beach, CA — Long Beach, California (9.9 mi)
· Sponsor: VA Office of Research and Development
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Clinical Research Institute, LCC — Los Angeles, California (16.1 mi)
· Sponsor: AbbVie
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Non-segmental Vitiligo
Phase 2
Interventional 45 participants sought
Marvel Clinical Research — Huntington Beach, California (23.1 mi)
· Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
First OC Dermatology Research — Fountain Valley, California (23.9 mi)
· Sponsor: Takeda
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Anaheim, California (24.5 mi)
· Sponsor: Axsome Therapeutics, Inc.
Regional Blocks for Lateral Condyle Fractures
Fractures, Closed, Humeral Fractures
Phase 4
Interventional 90 participants sought
Orthopaedic Institute for Children — Los Angeles, California (16.1 mi)
· Sponsor: University of California, Los Angeles
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Macula Retina Vitreous Research Institute — Torrance, California (0.1 mi)
· Sponsor: Genentech, Inc.
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Eye Physicians of Long Beach — Long Beach, California (9.9 mi)
· Sponsor: VisionCare, Inc.
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 168 participants sought
California Research Institute — Los Angeles, California (16.1 mi)
· Sponsor: OncoNano Medicine, Inc.
Study Evaluating the Quality and Effects of Lion's Mane Product on Cognitive Health
Cognitive Decline
N/A
Observational 150 participants sought
People Science — Los Angeles, California (16.1 mi)
· Sponsor: M2 Ingredients
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
Postpartum Hypertension (PPHT)
Phase 4
Interventional 110 participants sought
UCLA Ronald Reagan — Los Angeles, California (16.1 mi)
· Sponsor: University of California, Los Angeles